Joint with: The Ubiquitin Family in Biology and Disease
Proximity Based Biology and Therapeutics: Targeted Protein Degradation and Beyond
February 23-26, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Neil Bence, Cheryl Arrowsmith and Amit Choudhary
In Person
On Demand
February 23-26, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Neil Bence, Cheryl Arrowsmith and Amit Choudhary
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Carolyn R. Bertozzi †, Stanford University
Evolution and Development of the Field of Induced Proximity
Evolution and Development of the Field of Induced Proximity
Daphne Koller †, insitro
Transformation of Drug Discovery through Computational Biology
Transformation of Drug Discovery through Computational Biology
Ning Zheng †, University of Washington
AI Accelerated Virtual Screening for Novel Ligands
AI Accelerated Virtual Screening for Novel Ligands
Luca Naef †, VantAI
Application of AI/ML for Prediction of Novel Ternary Complexes and Glues
Application of AI/ML for Prediction of Novel Ternary Complexes and Glues
Short Talk(s) Chosen from Abstracts
Amit Choudhary, Harvard Medical School
Proximity-Inducing Molecules for Protein Editing
Proximity-Inducing Molecules for Protein Editing
Gerald R. Crabtree †, Stanford University
Transcriptional Chemical Inducers of Proximity
Transcriptional Chemical Inducers of Proximity
Daniel K. Nomura †, University of California, Berkeley
Protein Stability Control through DUBTAC Approaches
Protein Stability Control through DUBTAC Approaches
Short Talk(s) Chosen from Abstracts
Cheryl Arrowsmith, University of Toronto
Increasing the Repertoire of Chemically Recruitable E3 Ligases for Targeted Protein Degradation
Increasing the Repertoire of Chemically Recruitable E3 Ligases for Targeted Protein Degradation
Danette L. Daniels †, Foghorn Therapeutics, Inc
Novel Strategies of Targeting the Transcriptional Machinery for Degradation
Novel Strategies of Targeting the Transcriptional Machinery for Degradation
Gwenn Hansen †, Nurix Therapeutics
Enabling Novel Ligases for Targeted Protein Degradation through DEL based Approaches
Enabling Novel Ligases for Targeted Protein Degradation through DEL based Approaches
Miklos Bekes †, Arvinas
Hijacking Novel Ligase Such as KLHDC2 for Targeted Protein Degradation
Hijacking Novel Ligase Such as KLHDC2 for Targeted Protein Degradation
Short Talk(s) Chosen from Abstracts
Kat Kayser-Bricker †, Halda Therapeutics
Regulated Induced Proximity Targeting Chimeras (RIPTACs)
Regulated Induced Proximity Targeting Chimeras (RIPTACs)
Michelle R. Arkin †, University of California, San Francisco
Utilization of Stabilizers of Protein-Protein Interactions
Utilization of Stabilizers of Protein-Protein Interactions
John Knox †, Revolution Medicines
Targeting Activated Ras by Modulating Protein Complex Stability for the Treatment of Cancer
Targeting Activated Ras by Modulating Protein Complex Stability for the Treatment of Cancer
Short Talk(s) Chosen from Abstracts
Neil Bence, Bristol Myers Squibb
BMS Protein Degrader from Discovery to Clinical Development
BMS Protein Degrader from Discovery to Clinical Development
Paula O’Connor †, Nurix Therapeutics
Advancing Novel Degraders to the Clinic (BTK and Beyond)
Advancing Novel Degraders to the Clinic (BTK and Beyond)
Pamela Ting †, Novartis Institutes for BioMedical Research
Targeted Degradation of WIZ for gamma globin Derepression in Sickle Cell Disease
Targeted Degradation of WIZ for gamma globin Derepression in Sickle Cell Disease
Dan Sherman †, Arvinas Inc
BCL6 Protac for Lymphoma
BCL6 Protac for Lymphoma
Short Talk(s) Chosen from Abstracts
Georg E. Winter †, CeMM Research Center for Molecular Medicine
Novel Glue Discovery via Isogenic Morphological Profiling
Novel Glue Discovery via Isogenic Morphological Profiling
Mary E. Matyskiela †, Neomorph Inc.
Expanding the Target Space of Molecular Glue Degraders
Expanding the Target Space of Molecular Glue Degraders
Marie-Aude Guié †, X-Chem
Applications of AI/ML and Data Science for Discovering Novel Ternary Complexes for Molecular Glue Discovery
Applications of AI/ML and Data Science for Discovering Novel Ternary Complexes for Molecular Glue Discovery
Short Talk(s) Chosen from Abstracts
Monday, February 23, 2026
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, February 24, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Transformation of Drug Discovery and Induced Proximity through AI/ML
9:00–11:15 AM
Coffee Break
9:30–9:50 AM
On Own for Lunch
11:15–5:00 PM
Poster Setup
11:15–1:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight: Emerging Technologies and Approaches in Proximity Induction
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Novel Induced Proximity based Approaches
5:00–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, February 25, 2026
Breakfast
7:00–8:00 AM
Leveraging Novel Protein Degradation Machinery for Next Generation Protein Degraders
8:00–11:00 AM
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Poster Setup
11:00–1:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Induced Proximity to Modulate Protein Complexes
5:00–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, February 26, 2026
Breakfast
7:00–8:00 AM
Clinical Progress in Induced Proximity Approaches
8:00–11:00 AM
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Coffee Available
4:30–5:00 PM
Enabling Discovery and Development of Novel Induced Proximity Molecules and Glues
5:00–6:45 PM
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Friday, February 27, 2026
Departure
12:00–11:59 PM
Subscribe for Updates